Information Provided By: 
Fly News Breaks for December 2, 2016
BSX, NVCN
Dec 2, 2016 | 12:31 EDT
Leerink analyst Danielle Antalffy said Neovasc (NVCN) share are reacting positively to the announcement that Boston Scientific (BSX) is aquiring tissue manufacturing assets and a 15% stake on the company for $75M. The analyst said the deal significantly improves its ability to continue to operate regardless of the outcome of ongoing litigation and believes the likelihood that Neovasc can continue to operate has increased substantially. Antalffy rates Neovasc an Outperform.
News For NVCN;BSX From the Last 2 Days
